The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review
In this medfyle
People with both T2D and CKD have increased morbidity and mortality. Optimal glycaemic control is essential, it can be challenging to achieve targets in people with T2D+CKD. This narrative review looks at the hypoglycaemia risks with decreasing kidney function, and examines the role of basal insulin.
About this Medfyle
©2024 Medfyle. All rights reserved.
Original article:
Sloan L, Cheng AYY, Escalada J, Haluzík M, Mauricio D. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review. Diabetes Obes Metab. 2024 Apr;26(4):1157-1170. doi: 10.1111/dom.15425. Epub 2024 Jan 15. PMID: 38225217.
The authors of the original article had no part in the creation of the summary.
This Medfyle is provided as a service to healthcare professionals. It has been created from content originally published in Diabetes, Obesity and Metabolism, a Journal of pharmacology and therapeutics, by agreement with Wiley.
